Thursday, November 1, 2012
The recently announced oncology R&D collaboration between
Sanofi and Massachusetts General Hospital takes a
different tack than most translational research partnerships, as the two
parties are starting with insights gleaned from the bedside setting and are
working their way back to the bench. The partners have formed teams to take on
joint projects that will help formulate and test new hypotheses on how to best position
the pharma's cancer therapeutics and design the associated clinical programs.
K.-J. SciBX 5(43);
Published online Nov. 1, 2012
AND INSTITUTIONS MENTIONED
Massachusetts General Hospital, Boston, Mass.
Massachusetts General Hospital Cancer Center, Boston, Mass.
(Euronext:SAN; NYSE:SNY), Paris, France